Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Aptevo Therapeutics Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +3 vs. Q3 2023
- Shares held
- 1.93M
- −1.48M (−43.3%) vs. Q3 2023
- Total value
- $349.7K
- −$776.0K (−68.9%) vs. Q3 2023
- New holders
- 5
- 6 more added
- Sold out
- 2
- 7 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $224.3K |
| Q1 2026 | 9 | $229.7K |
| Q4 2025 | 11 | $191.4K |
| Q3 2025 | 12 | $717.1K |
| Q2 2025 | 7 | $45.9K |
| Q1 2025 | 8 | $22.8K |
| Q4 2024 | 13 | $208.7K |
| Q3 2024 | 19 | $231.1K |
| Q2 2024 | 18 | $599.1K |
| Q1 2024 | 10 | $12.4K |
| Q4 2023 | 29 | $349.7K |
| Q3 2023 | 26 | $1.13M |
| Q2 2023 | 23 | $1.36M |
| Q1 2023 | 24 | $1.82M |
| Q4 2022 | 27 | $2.27M |
| Q3 2022 | 27 | $2.63M |
| Q2 2022 | 27 | $2.85M |
| Q1 2022 | 24 | $4.76M |
| Q4 2021 | 23 | $5.99M |
| Q3 2021 | 26 | $42.1M |
| Q2 2021 | 29 | $65.5M |
| Q1 2021 | 34 | $89.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Aptevo Therapeutics Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 5 | $1 | 0.00% | −80−94.1% | Reduced |
| Bank of America Corp | 6 | $1 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 10 | $2 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 17 | $4 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 30 | $5 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 95 | $17 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 142 | $26 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 291 | $53 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,617 | $293 | 0.00% | +55+3.5% | Added |
| JPMorgan Chase & Co | 1,897 | $343 | 0.00% | −10−0.5% | Reduced |
| Divergent Wealth Advisors, LLC | 10,000 | $1.81K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 10,941 | $1.98K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 10,997 | $1.99K | 0.00% | 00.0% | Unchanged |
| Baader Bank INC | 15,086 | $2.03K | 0.00% | +15,086 | New |
| Two Sigma Securities, LLC | 11,248 | $2.04K | 0.00% | +11,248 | New |
| Morgan Stanley | 11,370 | $2.06K | 0.00% | +357+3.2% | Added |
| Tower Research Capital LLC (TRC) | 13,660 | $2.47K | 0.00% | +165+1.2% | Added |
| Northern Trust Corp | 14,121 | $2.56K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 43,201 | $7.82K | 0.00% | −32,154−42.7% | Reduced |
| BlackRock Inc. | 46,635 | $8.44K | 0.00% | −1,033−2.2% | Reduced |
| Cantor Fitzgerald, L. P. | 58,532 | $10.6K | 0.00% | +2,178+3.9% | Added |
| Armistice Capital, LLC | 61,130 | $11.1K | 0.00% | −1,173,870−95.1% | Reduced |
| Vanguard Group Inc | 91,725 | $16.6K | 0.00% | −129,339−58.5% | Reduced |
| Millennium Management LLC | 104,608 | $18.9K | 0.00% | +104,608 | New |
| Squarepoint Ops LLC | 138,697 | $25.1K | 0.00% | +138,697 | New |
| Schonfeld Strategic Advisors LLC | 159,000 | $28.8K | 0.00% | +16,200+11.3% | Added |
| Citadel Advisors LLC | 262,124 | $47.4K | 0.00% | +262,124 | New |
| Sabby Management, LLC | 349,471 | $63.3K | 0.56% | −984,698−73.8% | Reduced |
| Renaissance Technologies LLC | 516,789 | $94.0K | 0.00% | +340,809+193.7% | Added |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −46,200−100.0% | Sold out |
| Earnest Partners LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |